Shaanxi University of Chinese Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Xi'an China (1952)

Organization Overview

First Clinical Trial
2007
NCT00548223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shaanxi Hospital of Traditional Chinese Medicine | Shaanxi Provincial Hospital of Traditional Chinese Medicine | Shaanxi Traditional Chinese Medicine Hospital | Shaanxi University of Chinese Medicine | The Affiliated Hospital of Shaanxi University of Chinese Medicine | The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine | Yunnan Provincial Hospital of Traditional Chinese Medicine | Yunnan Provinical Hospital of Traditional Chinese Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blind Loop Syndrome (Phase 2)

Cerebral Infarction (Phase 4)

Cognitive Dysfunction (Phase 2)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Precancerous Conditions (Phase 2)

Psoriasis (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Stroke (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 24